Robert Don

1.3k total citations
12 papers, 699 citations indexed

About

Robert Don is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Organic Chemistry. According to data from OpenAlex, Robert Don has authored 12 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Organic Chemistry. Recurrent topics in Robert Don's work include Trypanosoma species research and implications (9 papers), Research on Leishmaniasis Studies (7 papers) and Synthesis and Biological Evaluation (6 papers). Robert Don is often cited by papers focused on Trypanosoma species research and implications (9 papers), Research on Leishmaniasis Studies (7 papers) and Synthesis and Biological Evaluation (6 papers). Robert Don collaborates with scholars based in Switzerland, United States and United Kingdom. Robert Don's co-authors include Robert T. Jacobs, Bakela Nare, Michael P. Barrett, Reto Brun, Michael Zhuo Wang, Farrokh Modabber, George E. Johnson, P. F. Greenfield, Shantha Liyanage and Tana Bowling and has published in prestigious journals such as PLoS neglected tropical diseases, Bioorganic & Medicinal Chemistry Letters and Parasitology.

In The Last Decade

Robert Don

12 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Don Switzerland	10	368	339	177	133	130	12	699
Esperanza Herreros Spain	20	202 0.5×	691 2.0×	304 1.7×	324 2.4×	84 0.6×	39	1.4k
Gillian M. Fisher Australia	13	146 0.4×	259 0.8×	336 1.9×	530 4.0×	144 1.1×	28	956
Sarah Arbe‐Barnes Switzerland	10	74 0.2×	571 1.7×	162 0.9×	177 1.3×	96 0.7×	16	880
Renée Lira Venezuela	12	699 1.9×	601 1.8×	414 2.3×	358 2.7×	104 0.8×	17	1.1k
Denise da Gama Jaén Batista Brazil	17	512 1.4×	432 1.3×	354 2.0×	152 1.1×	51 0.4×	34	717
Bärbel Bergmann Germany	20	168 0.5×	752 2.2×	120 0.7×	541 4.1×	191 1.5×	31	1.3k
Keyla Lazardi Venezuela	10	547 1.5×	424 1.3×	325 1.8×	244 1.8×	50 0.4×	11	839
Marta Machado Portugal	21	91 0.2×	357 1.1×	345 1.9×	213 1.6×	71 0.5×	37	859
Charlotte Lanteri United States	17	166 0.5×	515 1.5×	161 0.9×	151 1.1×	118 0.9×	35	740
Shailza Singh India	16	230 0.6×	243 0.7×	124 0.7×	384 2.9×	58 0.4×	99	879

Countries citing papers authored by Robert Don

Since Specialization

Citations

This map shows the geographic impact of Robert Don's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Don with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Don more than expected).

Fields of papers citing papers by Robert Don

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Don. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Don. The network helps show where Robert Don may publish in the future.

Co-authorship network of co-authors of Robert Don

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Don. A scholar is included among the top collaborators of Robert Don based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Don. Robert Don is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Modabber, Farrokh, et al.. (2015). A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. PLoS neglected tropical diseases. 9(9). e0003889–e0003889. 78 indexed citations

Planer, Joseph D., et al.. (2014). Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi. PLoS neglected tropical diseases. 8(7). e2977–e2977. 71 indexed citations

Wring, Stephen A., Eric Gaukel, Bakela Nare, et al.. (2013). Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis. Parasitology. 141(1). 104–118. 26 indexed citations

Bowling, Tana, Luke Mercer, Robert Don, Robert T. Jacobs, & Bakela Nare. (2012). Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis. International Journal for Parasitology Drugs and Drug Resistance. 2. 262–270. 65 indexed citations

Freeman, Jennifer C., Cyrus J. Bacchi, Tana Bowling, et al.. (2011). SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei. Bioorganic & Medicinal Chemistry Letters. 21(10). 2816–2819. 7 indexed citations

Olliaro, Piero, J.P. Seiler, Annette C. Kuesel, et al.. (2011). Potential Drug Development Candidates for Human Soil-Transmitted Helminthiases. PLoS neglected tropical diseases. 5(6). e1138–e1138. 68 indexed citations

Mercer, Luke, Tana Bowling, Jennifer C. Freeman, et al.. (2011). 2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach. PLoS neglected tropical diseases. 5(2). e956–e956. 29 indexed citations

Jacobs, Robert T., Jacob J. Plattner, & Robert Don. (2011). Molecule of the Month. Current Topics in Medicinal Chemistry. 11(10). 1301–1303. 4 indexed citations

Brun, Reto, Robert Don, Robert T. Jacobs, Michael Zhuo Wang, & Michael P. Barrett. (2011). Development of Novel Drugs for Human African Trypanosomiasis. Future Microbiology. 6(6). 677–691. 103 indexed citations

10.

Jacobs, Robert T., Jacob J. Plattner, Bakela Nare, et al.. (2011). Benzoxaboroles: A New Class of Potential Drugs for Human African Trypanosomiasis. Future Medicinal Chemistry. 3(10). 1259–1278. 68 indexed citations

11.

Ribeiro, Isabela, Fabiana Alves, Graciela Diap, et al.. (2009). New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients. PLoS neglected tropical diseases. 3(7). e484–e484. 122 indexed citations

12.

Liyanage, Shantha, P. F. Greenfield, & Robert Don. (1999). Towards a fourth generation R&D management model-research networks in knowledge management. International Journal of Technology Management. 18(3/4). 372–372. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact